Beck Mack & Oliver’s Amdocs DOX Stock Holding History

Beck Mack & Oliver’s Portfolio DOX Stock Details DOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,941	Closed	-$1.44M	–	197
2025 Q4	$1.44M	Buy	17,941 +110	+0.6%	+$8.84K	0.03%	102
2025 Q3	$1.46M	Buy	17,831 +106	+0.6%	+$9.19K	0.03%	95
2025 Q2	$1.62M	Buy	17,725 +108	+0.6%	+$9.65K	0.03%	88
2025 Q1	$1.61M	Buy	17,617 +90	+0.5%	+$7.86K	0.03%	90
2024 Q4	$1.49M	Buy	17,527 +93	+0.5%	+$8.16K	0.03%	90
2024 Q3	$1.53M	Buy	17,434 +98	+0.6%	+$8.25K	0.03%	91
2024 Q2	$1.37M	Hold	17,336	–	–	0.03%	94
2024 Q1	$1.57M	Buy	17,336 +81	+0.5%	+$7.38K	0.03%	92
2023 Q4	$1.52M	Buy	+17,255	New	+$1.44M	0.04%	91

Other funds holding DOX

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Beck Mack & Oliver's DOX Position: Q1 2026 in Review

Beck Mack & Oliver sold out of Amdocs (DOX) in Q1 2026, closing a stake of 17,941 shares — an estimated $1.44M sold.

Beck Mack & Oliver first reported a position in DOX in Q4 2023 and held it in 9 quarters. The position peaked at $1.62M in Q2 2025. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.

Beck Mack & Oliver reported no remaining Amdocs position as of Q1 2026 after selling out during the quarter.
Beck Mack & Oliver sold 17,941 Amdocs shares in Q1 2026, an estimated $1.44M.
Beck Mack & Oliver first reported a position in Amdocs in Q4 2023 and held it in 9 quarters.
Beck Mack & Oliver's Amdocs position peaked at $1.62M in Q2 2025.
473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.

Based on Beck Mack & Oliver's 13F filing for Q1 2026, filed 12 May 2026.